Outcomes of COVID-19 and Vaccination in Patients with Moderate to Severe Atopic Dermatitis Treated with Tralokinumab

Andrew Blauvelt; Andrew Pink; Margitta Worm; Richard G.B. Langley; Boni E. Elewski; Le Gjerum; Emma Guttman-Yassky

doi:10.1001/jamadermatol.2022.3488

Outcomes of COVID-19 and Vaccination in Patients with Moderate to Severe Atopic Dermatitis Treated with Tralokinumab

Andrew Blauvelt, Andrew Pink, Margitta Worm, Richard G.B. Langley, Boni E. Elewski, Le Gjerum, Emma Guttman-Yassky

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1327-1330
Number of pages	4
Journal	JAMA Dermatology
Volume	158
Issue number	11
DOIs	https://doi.org/10.1001/jamadermatol.2022.3488
Publication status	Published - Nov 16 2022
Externally published	Yes

ASJC Scopus Subject Areas

Dermatology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/jamadermatol.2022.3488

Cite this

@article{9812e973726c42e1b1cb84764a108840,

title = "Outcomes of COVID-19 and Vaccination in Patients with Moderate to Severe Atopic Dermatitis Treated with Tralokinumab",

author = "Andrew Blauvelt and Andrew Pink and Margitta Worm and Langley, {Richard G.B.} and Elewski, {Boni E.} and Le Gjerum and Emma Guttman-Yassky",

note = "Funding Information: Funding/Support: This study was supported by the Swedish Ministry of Health and Social Affairs.",

year = "2022",

month = nov,

day = "16",

doi = "10.1001/jamadermatol.2022.3488",

language = "English",

volume = "158",

pages = "1327--1330",

journal = "JAMA Dermatology",

issn = "2168-6068",

publisher = "American Medical Association",

number = "11",

}

TY - JOUR

T1 - Outcomes of COVID-19 and Vaccination in Patients with Moderate to Severe Atopic Dermatitis Treated with Tralokinumab

AU - Blauvelt, Andrew

AU - Pink, Andrew

AU - Worm, Margitta

AU - Langley, Richard G.B.

AU - Elewski, Boni E.

AU - Gjerum, Le

AU - Guttman-Yassky, Emma

N1 - Funding Information: Funding/Support: This study was supported by the Swedish Ministry of Health and Social Affairs.

PY - 2022/11/16

Y1 - 2022/11/16

UR - http://www.scopus.com/inward/record.url?scp=85140005313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85140005313&partnerID=8YFLogxK

U2 - 10.1001/jamadermatol.2022.3488

DO - 10.1001/jamadermatol.2022.3488

M3 - Letter

C2 - 36223087

AN - SCOPUS:85140005313

SN - 2168-6068

VL - 158

SP - 1327

EP - 1330

JO - JAMA Dermatology

JF - JAMA Dermatology

IS - 11

ER -

Outcomes of COVID-19 and Vaccination in Patients with Moderate to Severe Atopic Dermatitis Treated with Tralokinumab

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Cite this